In addition, SeNPs can substantially promote the cytotoxicity of CIK cells from cancer patients against tumor cells by increasing the expression of the activating receptor—NKG2D and its ligand, but are not toxic to CIK and tumor cells. Here, KLRK1 is linked to neoplasm.